New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 9, 2014
07:31 EDTBCLIBrainStorm Cell appoints Fiorino CEO
BrainStorm Cell Therapeutics announced that it has appointed Tony Fiorino as its new CEO. Previously, Fiorino was founder, president and CEO of EnzymeRx, where he led the acquisition of a late-stage pre-clinical biologic and the development of the compound through Phase 1/2 clinical trials and its subsequent sale to 3SBio.
News For BCLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
06:48 EDTBCLIBrainStorm receives $1.1M from Israel's OCS
BrainStorm Cell Therapeutics announced today that wholly-owned subsidiary Brainstorm Cell Therapeutics was awarded a grant of approximately $1.1M from Israel's Office of the Chief Scientist, or OCS. This is the eighth year that BrainStorm has been in receipt of grant support from the Office of the Chief Scientist, which is part of the Ministry of Trade and Industry Program to support innovative technologies in Israel. The funds will support the development NurOwn, BrainStorm's innovative mesenchymal stem cell-based platform for treating neurodegenerative diseases including BrainStorm's phase 2 clinical program in amyotrophic lateral sclerosis.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use